Trends of Lymph Node Outcomes in Partial Cystectomy for Muscle-Invasive Urothelial Carcinoma of the Bladder

被引:2
|
作者
Klose, Charles [2 ,3 ]
Gordon, Olivia
Sparks, Andrew [1 ]
Whalen, Michael
机构
[1] George Washington Univ, Dept Urol, Sch Med & Hlth Sci, Washington, DC USA
[2] East Carolina Univ, Brody Sch Med, Greenville, NC USA
[3] GWU Med Fac Associates, Dept Urol, 2150 Penn Ave NW, Suite 3-417sb, Washington, DC 20037 USA
关键词
Bladder Cancer; Pelvic Lymph Node Dissection; Regional Nodes Examined; Bladder Sparing; Node Yield; RADICAL CYSTECTOMY; CANCER;
D O I
10.1016/j.clgc.2023.05.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Local tumor invasion depth has been associated with lymph node metastasis in urothelial carcinoma, and, for muscle-invasive bladder cancer (MIBC), pelvic lymph node dissection (PLND) is a critical step in curative surgery. Gold standard treatment includes radical cystectomy (RC), but partial cystectomy (PC) is an important bladder -preserving modality reserved for patients with certain favorable prognostic indicators. There is poor evidence concerning the utility of PLND in PC and we seek to further define its role by comparing survival outcomes when PLND was cursory or omitted. Methods: A retrospective analysis of 13,652 cT2N0M0 patients who underwent PC or RC between 2004 and 2016 was performed using the National Cancer Database. Patients undergoing PC were stratified by the presence of PLND as well as by node yield > 15. The primary outcome was overall survival, analyzed using the Kaplan-Meier Method and multivariable Cox-proportional hazards regression. Multivariable models were adjusted for confounding clinicopathologic variables. Results: From 2004 to 2016, PLND in PC increased from 44% to 57% with RC remaining over 90%. Compared to RC, PC was approximately twice as likely to be performed at community centers and approached laparoscopically/robotically ( P < .001). When stratifying PC PLND yield into 1 to 15 and > 15 compared to PC without PLND, the adjusted hazard ratios for overall mortality were 0.78 and 0.54, respectively ( P < .05). Conclusions: PC patients had a significantly lower rate of PLND compared to RC and improved survival when performed versus PC alone. Furthermore, increased node yield was associated with a larger reduction of adjusted mortality hazard. For MIBC patients that are appropriately selected for PC, high-yield PLND should be pr ior itized given the significantly improved survival outcomes.
引用
收藏
页码:703 / 709
页数:7
相关论文
共 50 条
  • [41] Retrospective analysis of partial cystectomy in patients with muscle-invasive urothelial carcinoma: A German single-center experience
    Schmidt, Jacob
    Furlano, Kira
    Kellmer, Patricia
    Krause, Hans
    Klatte, Tobias
    Miller, Kurt
    Schlomm, Thorsten
    Hofbauer, Sebastian L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [42] A comparative study of survival outcomes between partial and radical cystectomy in octogenarians with muscle-invasive bladder cancer
    Avudaiappan, Arjun Pon
    Prabhakar, Pushan
    Lusnia, Ciara
    Ganiyani, Mohmmad Arfat
    Rubens, Muni
    Garje, Rohan
    Eldefrawy, Ahmed
    Manoharan, Murugesan
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (08) : 1486 - 1497
  • [43] Alternatives to cystectomy in muscle-invasive bladder cancer
    Goel, S
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 3003 - 3003
  • [44] PROGNOSIS OF PRIMARY AND PROGRESSIVE MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA - IS THERE A DIFFERENCE?
    Ciudin, A.
    Molina Cabeza, A.
    Huguet Perez, J.
    Goicoechea Maturana, I
    Peri Cusi, L.
    Ribal Caparros, M. J.
    Alcaraz Asensio, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 241 - 241
  • [45] THERMOCHEMOTHERAPY: AN ALTERNATIVE TREATMENT FOR NON MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER?
    Roth, Beat
    Schneider, Silvia
    Thalmann, George N.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E705 - E705
  • [46] Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder
    Mossanen, Matthew
    Lee, Franklin
    Cheng, Heather
    Harris, William
    Shenoi, Jaideep
    Zhao, Song
    Wang, Junfeng
    Champion, Thomas
    Izard, Jason
    Gore, John L.
    Porter, Michael P.
    Yu, Evan Y.
    Wright, Jonathan L.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (03) : 210 - 213
  • [47] Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma
    Duplisea, Jonathan J.
    Mason, Ross J.
    Reichard, Chad A.
    Li, Roger
    Shen, Yu
    Boorjian, Stephen A.
    Dinney, Colin P.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (02): : 24 - 28
  • [48] Pathological pelvic lymph node involvement in muscle-invasive bladder cancer patients treated with radical cystectomy: A narrative review
    Gabriel, P. -E.
    Pinar, U.
    Parra, J.
    Vaessen, C.
    Mozer, P.
    Chartier-Kastler, E.
    Roupret, M.
    Seisen, T.
    PROGRES EN UROLOGIE, 2023, 33 (03): : 145 - 154
  • [49] Outcomes of Single Lymph Node Positive Urothelial Carcinoma After Radical Cystectomy
    Jeong, In Gab
    You, Dalsan
    Kim, Jong Won
    Song, Cheryn
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2011, 185 (06): : 2085 - 2090
  • [50] Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle-Invasive Bladder Cancer in the United States
    Davies-Teye, Bernard Bright
    Siddiqui, M. Minhaj
    Zhang, Xiao
    Johnson, Abree
    Burcu, Mehmet
    Onukwugha, Eberechukwu
    Hanna, Nader
    CANCER MEDICINE, 2025, 14 (04):